Autoimmunity & Inflammation Program

 

Autoimmunity & Inflammation Program

The Autoimmunity and Inflammation Program includes research into the origins and therapeutic modulation of autoimmune destruction of the islet in Type 1 diabetes and into the role of inflammation in Type 2 diabetes. Research within the program has led to novel insights into the surveillance of islet antigens leading to type 1 diabetes, the central role of the breakdown in T cell tolerance in that immune attack on the islet and the role of the immune system in reducing the response of tissues to insulin, leading to type 2 diabetes.

Autoimmunity & Inflammation Program Members

Abbas, Abul
Anderson, Mark
Ansel, Mark
Bluestone, Jeffrey
Cyster, Jason
Krummel, Matthew
Lainer, Lewis
Locksley, Richard
Marson, Alex
McManus, Michael
Rosenblum, Mike
Sanda, Srinath
Tang, Qizhi
Weiss, Arthur
Wofsy, David

 

CENTER MEMBERS ARE REMINDED TO ACKNOWLEDGE DERC CENTER GRANT (P30 DK063720) CONTRIBUTIONS WITH ‘THIS RESEARCH WAS SUPPORTED BY GRANTS X, Y FROM NIH P30 DK063720'.